Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2

Journal of Membrane Biology

Volumn 246, Issue 12, 2013, Pages 885-892

  Warsi, Jamshed ^a   Hosseinzadeh, Zohreh ^a   Dong, Luo ^a   Pakladok, Tatsiana ^a   Umbach, Anja T ^a   Bhavsar, Shefalee K ^a   Shumilina, Ekaterina ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Janus kinase; Peptide transport; Tumor cell

Indexed keywords

4 [(3' BROMO 4' HYDROXYPHENYL)AMINO] 6,7 DIMETHOXYQUINAZOLINE; DIPEPTIDE; JANUS KINASE 3; JANUS KINASE 3 INHIBITOR; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; RNA; UNCLASSIFIED DRUG; WHI P 154;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CHEMOLUMINESCENCE; ENZYME ACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; UPREGULATION; VOLTAGE CLAMP; XENOPUS;

MUS;

ANIMALS; FEMALE; GENE EXPRESSION; HUMANS; JANUS KINASE 3; MALE; MICE; MICE, KNOCKOUT; OOCYTES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; SYMPORTERS; XENOPUS;

EID: 84888290716     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-013-9582-3     Document Type: Article

References (46)

1. Alesutan I, Sopjani M, Dermaku-Sopjani M, Munoz C, Voelkl J, Lang F (2012) Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2. Cell Physiol Biochem 30:458-465
2. Alteheld B, Evans ME, Gu LH, Ganapathy V, Leibach FH, Jones DP, Ziegler TR (2005) Alanylglutamine dipeptide and growth hormone maintain PepT1-mediated transport in oxidatively stressed Caco-2 cells. J Nutr 135:19-26
3. Ananthakrishnan R, Hallam K, Li Q, Ramasamy R (2005) JAK-STAT pathway in cardiac ischemic stress. Vascul Pharmacol 43:353-356
4. Bhavsar SK, Gu S, Bobbala D, Lang F (2011) Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 27:547-556
5. Boehmer C, Palmada M, Klaus F, Jeyaraj S, Lindner R, Laufer J, Daniel H, Lang F (2008) The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2. Cell Physiol Biochem 22:705-714
6. Brandsch M (2009) Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls. Expert Opin Drug Metab Toxicol 5:887-905
7. Candotti F, Oakes SA, Johnston JA, Giliani S, Schumacher RF, Mella P, Fiorini M, Ugazio AG, Badolato R, Notarangelo LD, Bozzi F, Macchi P, Strina D, Vezzoni P, Blaese RM, O'Shea JJ, Villa A (1997) Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90:3996-4003
8. Chen M, Cheng A, Candotti F, Zhou YJ, Hymel A, Fasth A, Notarangelo LD, O'Shea JJ (2000) Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol 20:947-956
9. de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, Balleari E, Gobbi M, Cutrona G, Ferrarini M, Ferrini S (2008) The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 111:517-524
10. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F (2011) Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 28:251-258
11. Foley DW, Rajamanickam J, Bailey PD, Meredith D (2010) Bioavailability through PepT1: the role of computer modelling in intelligent drug design. Curr Comput Aided Drug Des 6:68-78
12. Ghoreschi K, Laurence A, O'Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273-287
13. Gonzalez DE, Covitz KM, Sadee W, Mrsny RJ (1998) An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res 58:519-525
14. Haan C, Rolvering C, Raulf F, Kapp M, Druckes P, Thoma G, Behrmann I, Zerwes HG (2011) Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors. Chem Biol 18:314-323
15. Henrion U, Zumhagen S, Steinke K, Strutz-Seebohm N, Stallmeyer B, Lang F, Schulze-Bahr E, Seebohm G (2012) Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel. Cell Physiol Biochem 29:809-818
16. Hosseinzadeh Z, Bhavsar SK, Shojaiefard M, Saxena A, Merches K, Sopjani M, Alesutan I, Lang F (2011a) Stimulation of the glucose carrier SGLT1 by JAK2. Biochem Biophys Res Commun 408:208-213
17. Hosseinzadeh Z, Bhavsar SK, Sopjani M, Alesutan I, Saxena A, Dermaku-Sopjani M, Lang F (2011b) Regulation of the glutamate transporters by JAK2. Cell Physiol Biochem 28:693-702
18. Hosseinzadeh Z, Bhavsar SK, Lang F (2012) Downregulation of ClC-2 by JAK2. Cell Physiol Biochem 29:737-742
19. Hosseinzadeh Z, Dong L, Bhavsar SK, Almilaji A, Lang F (2013) Upregulation of peptide transporters PepT1 and PepT2 by Janus kinase JAK2. Cell Physiol Biochem 31:673-682
20. Ingersoll SA, Ayyadurai S, Charania MA, Laroui H, Yan Y, Merlin D (2012) The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302:G484-G492
21. Inoue M, Terada T, Okuda M, Inui K (2005) Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs. Cancer Lett 230:72-80
22. Kamal MA, Keep RF, Smith DE (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet 23:236-242
23. Kim BH, Oh SR, Yin CH, Lee S, Kim EA, Kim MS, Sandoval C, Jayabose S, Bach EA, Lee HK, Baeg GH (2010) MS-1020 is a novel small molecule that selectively inhibits JAK3 activity. Br J Haematol 148:132-143
24. Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L, Chong SC, Ong WS, Tay K, Tao M, Quek R, Loong S, Yeoh KW, Yap SP, Lee KA, Lim LC, Tan D, Goh C, Cutcutache I, Yu W, Ng CC, Rajasegaran V, Heng HL, Gan A, Ong CK, Rozen S, Tan P, Teh BT, Lim ST (2012) Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov 2:591-597
25. Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C, Villeval JL, Reinhardt D, Landman-Parker J, Michaux L, Dastugue N, Baruchel A, Vainchenker W, Bourquin JP, Penard-Lacronique V, Bernard OA (2008) Activating mutations in human acute megakaryoblastic leukemia. Blood 112:4220-4226
26. Meredith D (2009) The mammalian proton-coupled peptide cotransporter PepT1: sitting on the transporter-channel fence? Philos Trans R Soc Lond B Biol Sci 364:203-207
27. Mitsuoka K, Kato Y, Miyoshi S, Murakami Y, Hiraiwa M, Kubo Y, Nishimura S, Tsuji A (2010) Inhibition of oligopeptide transporter suppresses growth of human pancreatic cancer cells. Eur J Pharm Sci 40:202-208
28. Nagel S, Papadakis M, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S (2012) Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia. Neuroscience 208:109-122
29. Nakamura T, Yamamori M, Sakaeda T (2008) Pharmacogenetics of intestinal absorption. Curr Drug Deliv 5:153-169
30. Nakayama J, Yamamoto M, Hayashi K, Satoh H, Bundo K, Kubo M, Goitsuka R, Farrar MA, Kitamura D (2009) BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood 113:1483-1492
31. Newstead S (2011) Towards a structural understanding of drug and peptide transport within the proton-dependent oligopeptide transporter (POT) family. Biochem Soc Trans 39:1353-1358
32. Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Perez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF (2000) Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol Rev 178:39-48
33. Pathare G, Foller M, Daryadel A, Mutig K, Bogatikov E, Fajol A, Almilaji A, Michael D, Stange G, Voelkl J, Wagner CA, Bachmann S, Lang F (2012) OSR1-sensitive renal tubular phosphate reabsorption. Kidney Blood Press Res 36:149-161
34. Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O'Shea JJ (2005) Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunol Rev 203:127-142
35. Pieri M, Christian HC, Wilkins RJ, Boyd CA, Meredith D (2010) The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase. Am J Physiol Gastrointest Liver Physiol 299:G136-G143
36. Rexhepaj R, Rotte A, Pasham V, Gu S, Kempe DS, Lang F (2010) PI3 kinase and PDK1 in the regulation of the electrogenic intestinal dipeptide transport. Cell Physiol Biochem 25:715-722
37. Rubio-Aliaga I, Daniel H (2008) Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38:1022-1042
38. Strutz-Seebohm N, Pusch M, Wolf S, Stoll R, Tapken D, Gerwert K, Attali B, Seebohm G (2011) Structural basis of slow activation gating in the cardiac I Ks channel complex. Cell Physiol Biochem 27:443-452
39. Tai W, Chen Z, Cheng K (2013) Expression profile and functional activity of peptide transporters in prostate cancer cells. Mol Pharm 10:477-487
40. Thomis DC, Lee W, Berg LJ (1997) T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis. J Immunol 159:4708-4719
41. Tsume Y, Hilfinger JM, Amidon GL (2008) Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability. Mol Pharm 5:717-727
42. Uckun FM, Vassilev A, Dibirdik I, Tibbles H (2007) Targeting JAK3 tyrosine kinase-linked signal transduction pathways with rationally-designed inhibitors. Anticancer Agents Med Chem 7:612-623
43. Vijayakrishnan L, Venkataramanan R, Gulati P (2011) Treating inflammation with the Janus kinase inhibitor CP-690,550. Trends Pharmacol Sci 32:25-34
44. Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M, Goss VL, Lee KA, Eide CA, Wong MJ, Stoffregen EP, McGreevey L, Nardone J, Moore SA, Crispino J, Boggon TJ, Heinrich MC, Deininger MW, Polakiewicz RD, Gilliland DG, Druker BJ (2006) Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 10:65-75
45. Wang G, Qian P, Jackson FR, Qian G, Wu G (2008) Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells. Int J Biochem Cell Biol 40:461-470
46. Yarandi SS, Hebbar G, Sauer CG, Cole CR, Ziegler TR (2011) Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation. Nutrition 27:269-275